24 Nov

Application for quotation of securities - MXC

Application for quotation of +securities Application for quotation of +securities 1 / 6 Announcement Summary Entity name MGC PHARMACEUTICALS LTD Announcement Type New announcement Date of this announcement Wednesday November 24, 2021 The +securities to be quoted are: Total number of +securities to be quoted ASX +security code Security description Number of +securities to be quoted Issue date MXC ORDINARY FULLY PAID 17,923,153 24/11/2021 Refer to next page for full details of the announcement +Securities issued as part of a transaction or transactions previously announced to the market in an Appendix 3B Application for quotation of +securities Application for quotation of +securities 2 / 6 Part 1 - Entity and announcement details 1.1 Name of entity MGC PHARMACEUTICALS LTD We (the entity named above) apply for +quotation of the following +securities and agree to the matters set out in Appendix 2A of the ASX Listing Rules. 1.2 Registered number type ABN Registration number 30116800269 1.3 ASX issuer code MXC 1.4 The announcement is 1.5 Date of this announcement 24/11/2021 New announcement Application for quotation of +securities Application for quotation of +securities 3 / 6 Part 2 - Type of Issue 2.1 The +securities to be quoted are: Previous Appendix 3B details: Announcement Date and Time 22-Apr-2021 17:55 Announcement Title New - Proposed issue of Securities - MXC Selected Appendix 3B to submit quotation request A placement or other type of issue 2.3a.2 Are there any further issues of +securities yet to take place to complete the transaction(s) referred to in the Appendix 3B? 2.3a.3 Please provide details of the further issues of +securities yet to take place to complete the transaction(s) referred to in the Appendix 3B The balance of the deferred consideration securities remain due, in accordance with the Acquisition Agreement announced on 22 April 2021 Yes +Securities issued as part of a transaction or transactions previously announced to the market in an Appendix 3B Application for quotation of +securities Application for quotation of +securities 4 / 6 Part 3A - number and type of +securities to be quoted where issue has previously been notified to ASX in an Appendix 3B Placement Details ASX +security code and description MXC : ORDINARY FULLY PAID Issue date 24/11/2021 Distribution Schedule Provide a distribution schedule for the new +securities according to the categories set out in the left hand column - including the number of recipients and the total percentage of the new +securities held by the recipients in each category. Number of +securities held Number of holders Total percentage of +securities held For example, to enter a value of 50% please input as 50.00 1 - 1,000 % 1,001 - 5,000 % 5,001 - 10,000 % 10,001 - 100,000 1 0.43 % 100,001 and over 10 99.57 % Application for quotation of +securities Application for quotation of +securities 5 / 6 Issue details Number of +securities to be quoted 17,923,153 Are the +securities being issued for a cash consideration? Please describe the consideration being provided for the +securities Shares in a company acquired in the acquisition announced on 22 April 2021 Please provide an estimate (in AUD) of the value of the consideration being provided per +security for the +securities to be quoted 0.067000 Any other information the entity wishes to provide about the +securities to be quoted No No Application for quotation of +securities Application for quotation of +securities 6 / 6 Part 4 - Issued capital following quotation Following the quotation of the +securities the subject of this application, the issued capital of the entity will comprise: (A discrepancy in these figures compared to your own may be due to a matter of timing if there is more than one application for quotation/issuance currently with ASX for processing.) 4.1 Quoted +securities (total number of each +class of +securities quoted on ASX following the +quotation of the +securities subject of this application) ASX +security code and description Total number of +securities on issue MXC : ORDINARY FULLY PAID 2,422,019,008 4.2 Unquoted +securities (total number of each +class of +securities issued but not quoted on ASX) ASX +security code and description Total number of +securities on issue MXCAF : OPTION EXPIRING VARIOUS DATES EX VARIOUS PRICES 51,300,000 MXCAG : PERFORMANCE RIGHTS 33,300,000 MXCAAA : CONVERTIBLE NOTES 2,100,000 MXCAAB : CLASS A PERFORMANCE RIGHTS 17,100,000 MXCAAC : CLASS B PERFORMANCE RIGHTS 39,900,000 MXCAAD : CLASS C PERFORMANCE RIGHTS 6,600,000 MXCAH : OPTION EXPIRING 31-MAR-2023 EX $0.026 7,692,308 MXCAI : OPTION EXPIRING 31-MAR-2023 EX GBP0.01475 26,440,678 MXCAAE : CLASS D PERFORMANCE RIGHTS 250,000 MXCAAF : CLASS E PERFORMANCE RIGHTS 250,000

More from MGC Pharmaceuticals Ltd


Join Listcorp to create a personalised news feed, follow your favourite companies, save useful news, and more.

By joining Listcorp you agree to our Terms & Conditions and Privacy Policy

Information on this Website is provided for general information purposes only and is not a substitute for professional advice. ASX Information (including company announcements and prices) is delayed by at least 20 minutes. JSE Information (including company announcements and prices) is delayed by at least 15 minutes. Reliance on the information you access on or from this Website is solely at your own risk. We make no representation or warranty in relation to the future performance of the companies that appear on this Website. Investment in securities involves risk and you should obtain independent professional legal, financial, investment or company advice before acting on any of the information you access on this Website. Using, browsing or otherwise accessing this Website is subject to our Terms and Conditions and our Privacy Policy.

© 2021 Listcorp. ABN 60 166 140 307

Never miss news from MGC Pharmaceuticals Ltd (ASX:MXC) when you join Listcorp.